Assignee
ABCLON INC
KR8 patents
Top patents by PatentIndex Score
US10174116B2Jan 8, 2019
Antibody specifically binding to HER2
ABCLON INC7 citations68
US12414998B2Sep 16, 2025
Anti-HER2 affibody and switchable chimeric antigen receptor using same as switch molecule
ABCLON INC0 citations62
US12090171B2Sep 17, 2024
Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof
ABCLON INC0 citations61
US11534462B2Dec 27, 2022
Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof
ABCLON INC0 citations61
US11248059B2Feb 15, 2022
Antibody having improved stability and specifically binding to HER2
ABCLON INC0 citations61
US10465008B2Nov 5, 2019
Antibodies against vascular endothelial growth factor receptor 2 (VEGFR2), encoding nucleic acid molecules and methods for treating an angiogenesis-related disease
ABCLON INC0 citations51
US11708409B2Jul 25, 2023
Antibody or antigen-binding fragment thereof that specifically recognizes B cell malignancies, chimeric antigen receptor comprising same, and uses thereof
ABCLON INC0 citations50
US11945878B2Apr 2, 2024
Switch molecule and switchable chimeric antigen receptor
ABCLON INC0 citations41